$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
How long should you use ruxolitinib cream (Opzelura) and long-term medication observation guidance?
2026-02-01 22:25:32
Check Details
Is it necessary to insist on taking the full course of Epclusa medication and analysis of the risks of discontinuation of medication?
2026-02-01 22:25:32
Check Details
How long should you take Sunitinib (Sutent) before you can stop taking it and what are the suggestions for observing the course of treatment?
2026-02-01 22:25:32
Check Details
The main types of diseases and clinical applications treated by tazetostat (Davico)
2026-02-01 22:25:32
Check Details
Ceritinib/Ceritinib (Zanda) belongs to which generation of drugs and analysis of its clinical significance
2026-02-01 22:25:32
Check Details
Besotivan (Viliru) is not suitable for users and its contraindications
2026-02-01 22:25:32
Check Details
Dabrafenib (Tefila) daily dosage and safe dosage range instructions
2026-02-01 22:25:32
Check Details
The half-life of axitinib (Inlida) and its impact on the dosing interval
2026-02-01 22:25:32
Check Details
Observation on the efficacy and long-term use of trametinib (Megenin) in patients with lung cancer
2026-02-01 22:25:32
Check Details
Is avatrombopag (Sucoxin) a hormonal drug and its differences
2026-02-01 22:25:32
Check Details
Safety and risk of adverse reactions of long-term use of giritinib (segatan)
2026-02-01 22:25:32
Check Details
Analysis of the efficacy and risk of worsening of lung cancer treated with Canafenib/Encofenib (Betavit)
2026-02-01 22:25:32
Check Details
1
2
...
2066
2067
2068
2069
2070
2071
2072
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma